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Background
Accumulation of neurotoxic mutated huntingtin protein
(Htt) is an important contributing factor to the pathogen-
esis of Huntington’sd i s e a s e( H D ) .M o r ea n dm o r ee v i -
dence has showed that wild-type Htt plays important roles
in maintaining normal functions of neuronal system. The
clearance of mutant Htt has been studied extensively;
however, little is known about the mechanisms regulating
accumulation and turnover of endogenous wild-type Htt.
Puromycin-sensitive aminopeptidase (PSA) was recently
identified as a major peptidase digesting TAU protein and
protecting against TAU-induced neurodegeneration. PSA
was also found as the peptidase responsible for digesting
polyglutamine sequences released by proteasomes and
removal of neurotoxic polyglutamine-expanded Htt exon-
1, ataxin-3, mutant synuclein and superoxide dismutase 1
via autophagy system. These results suggest that PSA
might represent a novel degradation mechanism targeting
aggregate-prone neurotoxic protein substrates, including
mutated Htt. However, the effects of PSA on endogenous
wild-type Htt abundance remain unclear. Here, we investi-
gated the effects of PSA on endogenous wild-type Htt
clearance in vivo using a PSA overexpressing transgenic
murine model and in vitro using human neuroblastoma
cell line.
Methods
We first determined whether PSA regulates Htt abundance
in vivo using a human PSA (hPSA) transgenic mouse
model, which was generated using bacterial artificial chro-
mosome (BAC) mediated technology. For measuring the
Htt expression in hPSA transgenic mice and control mice,
the brain tissues were dissected and separated, and then
were homogenized by sonication followed with centrifuga-
tion at 100,000 g at 4
oC. Htt in supernatants were analyzed
by Western blot using anti-Htt antibodies. Immunohisto-
chemistry was also performed using perfused brains from
both hPSA and control mice according to standard proto-
cols. And we tested whether PSA overexpression is able
to reduce the abundance of endogenous Htt in human
neuroblastoma cells SH-SY5Y in vitro. SH-SY5Y cells were
transfected with hPSA overexpression vectors pCMV6-XL-
hPSA or blank vectors and then the endogenous Htt was
analyzed with Western blot and immunocytochemistry.
We also investigated the effect of inhibition of PSA expres-
sion using RNA interference (Stealth-RNAi) on endogen-
ous Htt levels in SH-SY5Y cells. Cells were transfected
with siRNA oligonucleotides specific for hPSA. Efficient
hPSA silencing was confirmed with both real-time RT-
PCR and Western blot analysis.
Results
In vivo studies, Western blot analysis showed that Htt is
significantly decreased in human PSA transgenic mice.
Immunohistochemical experiment also showed Htt
expression is decreased in all the transgenic brain
regions tested. In vitro studies, Western blot analysis
demonstrated decrease of endogenous Htt in response
to PSA overexpression and accumulation of Htt in
response to PSA slicing with Stealth-RNAi in human
neuroblastoma cell line SH-SY5Y. And immunocyto-
chemistry demonstrated notable decrease and rapid
accumulation of Htt in response to PSA overexpression
and PSA slicing respectively in SH-SY5Y cells.
Conclusion
These combined in vivo and in vitro data implicate that
PSA may be a key physiological regulator of clearance
and turnover of wild-type Htt in neuronal system, and
may play important roles in pathogenesis of HD through
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well.
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